Beck Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Beck Capital Management's LLY Position: Q1 2026 in Review
Beck Capital Management increased its Eli Lilly (LLY) stake by 2% in Q1 2026, buying an estimated $122K and bringing the position to 6,202 shares worth $5.7M. The position accounts for 1.31% of the portfolio, ranked #29.
Beck Capital Management first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $8.08M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Beck Capital Management held 6,202 shares of Eli Lilly worth $5.7M as of Q1 2026.
- Beck Capital Management bought 120 Eli Lilly shares in Q1 2026, an estimated $122K.
- Eli Lilly made up 1.31% of Beck Capital Management's portfolio in Q1 2026, its #29 holding.
- Beck Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
- Beck Capital Management's Eli Lilly position peaked at $8.08M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Beck Capital Management's 13F filing for Q1 2026, filed 15 May 2026.